BONE AND JOINT HEALTH INGREDIENTS MARKET ANALYSIS

Market Challenges And Opportunities

Global Bone and Joint Health Ingredients Market Drivers:

Growing number of osteoporosis, rheumatoid arthritis, and osteoarthritis cases globally to uplift market growth

According to the Centers for Disease Control and Prevention (CDC), there are more than hundred types of arthritis conditions affecting more than one in four adult consumers worldwide. Furthermore, doctor-diagnosed arthritis is more common globally in women, in comparison to that of the male population, however, in some types, such as rheumatoid arthritis, women far outnumber men. As per the data stated by World Health Organization (WHO), prevalence of rheumatoid arthritis worldwide, ranges between 0.3% and 1%, affecting more number of women than men, and is more common in developed countries.

Increasing demand for herbal and natural ingredients to augment market growth

Natural and herbal ingredients have immense potential in joints and bone health supplements owing to their specific health benefits. Due to this pharma companies are incorporating natural ingredients into various food and beverage products. Omya AG which is a producer of industrial minerals offers its Calcipur range of natural calcium carbonates. This all-round ingredient optimizes production processes and formulations, but is also a supreme fortification agent. These natural range of calcium carbonates are naturally sourced and possess high bioavailability, supporting bone health as well as the proper functioning of muscles and nerves.

Global Bone and Joint Health Ingredients Market Opportunities:

Increasing incorporation of Vitamin K2 in functional foods as they have potential to treat condition like osteoporosis is projected to serve major growth opportunities. For instance, in October 2022, Biotech innovator, Conagen announced the development of its fermentation-derived vitamin K2 - a high-purity all-trans menaquinone-7 (MK-7).  This is the first molecule from a proprietary platform for producing novel, pure, long-chain menaquinone forms of the vitamin. Vitamin K2 helps to regulate calcium mobility in bones and restricts calcium buildup in blood vessels, leading to stroke and heart disease.

Increasing focus of key players on introducing novel products to cater to growing demand is projected to serve major growth opportunities. For instance, in January 2018, ADM announced the launch of non-GMO ingredient, Onavita™ Flaxseed Oil, applicable to supplements. The ingredient also caters to the vegetarian and vegan population.

• Clinical challenges associated with the dietary supplement 
• High cost of R &D and clinical trials

Global Bone and Joint Health Ingredients Market Restraints:

Clinical challenges associated with the dietary supplement to hinder market growth

For example, a systematic  review and meta-analysis published in the Journal of the American Medical Association in 2017 did not ‘support the routine use’ of calcium, vitamin D or both to prevent fractures in community-dwelling older adults. Moreover, there have been allergic cases especially with vitamins segment

High cost of R &D and clinical trials to restrict market growth

High investment required for R &D and clinical trials is another key factor hampering bone and joint health ingredients market growth. However, growing prevalence of chronic disease is projected to create demand for functional food.